BERKELEY, CA – Caribou Biosciences and DuPont jointly announce today that they have formed a strategic alliance designed to advance the two companies’ respective CRISPR-derived genome editing technology platforms. This multi-faceted agreement includes the cross-licensing of key intellectual property, a research collaboration, and financial investments by DuPont in Caribou, a developer of CRISPR-Cas technologies. Under […]
Denville, NJ — Diagenode, Inc., a leading global provider of complete solutions for epigenetics research, today announced the launch of a number of new reagent solutions to study nucleosomes and histones, the structural and functional units of chromatin. The new tools which include recombinant histones and nucleosomes, native nucleosomes, and a chromatin assembly kit, enable […]
IRVINE, Calif. — Celemics, a global pioneer of personalized medicine genetics, today announced its expansion into the North American market with the establishment of Celemics America, Inc. – Expansion aims to provide increased accessibility to proprietary target enrichment technology to increase performance of Next Generation Sequencing applications. Celemics, the first Next Generation Sequencing test kit […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that the Cerilliant® brand within its Applied Diagnostics and Testing business segment has launched its new bile acid reference standards product line with ten certified Snap-N-Spike® solutions of the most routinely tested bile acids and their stable-labeled internal standards. These new solution certified reference materials (CRMs) […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today launched an enhanced portfolio of training courses to match the needs of the company’s global customers in terms of location, format and timeframe. Agilent University, a long-trusted source of traditional classroom and customized onsite training, now offers online courses that cover foundational, intermediate and advanced […]
SAN DIEGO – Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”), a leader in the development of specialized cells for regenerative medicine and pharmaceutical drug discovery, today announced plans to form a commercial business for the banking of human induced pluripotent stem cells (iPSCs) by private individuals. Allele is pleased to have Drs. Mahendra Rao and Joseph […]
BELLSHILL, SCOTLAND: LINK (www.linktech.co.uk), the innovative developer and manufacturer of nucleic acid reagents, is now offering substantial discounts through specially selected product bundles. Responding to its users’ needs for low-cost easy access reagents, LINK has created each bundle to provide scientists with both established and new reagents to evaluate, while saving up to 40% off […]
Cambridge, UK: Abcam plc, a global leader in the supply of life sciences research tools, today announced the launch of its anti-PD-L1 primary antibody (clone 28-8). Produced using Abcam’s RabMAb® recombinant monoclonal antibody technology, the clone offers highly specific and reproducible antigen recognition to a checkpoint inhibitor critical to current cancer immunology research. Programmed-death ligand […]
AMSBIO has launched a unique series of monoclonal and polyclonal antibodies against S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) that allows immunoassays to be used in methylation regulation research. Methylation is involved in nearly every aspect of life. SAM is the sole methyl donor for a variety of methyl-transfer reactions in DNA, RNA, proteins, lipids, phosphilipids, hormones […]
AMSBIO has launched a unique series of monoclonal and polyclonal antibodies against S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) that allows immunoassays to be used in methylation regulation research. Methylation is involved in nearly every aspect of life. SAM is the sole methyl donor for a variety of methyl-transfer reactions in DNA, RNA, proteins, lipids, phosphilipids, hormones […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
